You can buy or sell CNSP and other stocks, options, ETFs, and crypto commission-free!
CNS Pharmaceuticals, Inc. Common Stock, also called CNS Pharmaceuticals, is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Read More Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
52 Week High
52 Week Low
— per share
Expected May 7, After Hours